S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
The Financial Day of Reckoning Has Begun (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
The Financial Day of Reckoning Has Begun (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
The Financial Day of Reckoning Has Begun (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
The Financial Day of Reckoning Has Begun (Ad)
NYSE:LH

Laboratory Co. of America - LH Price Target & Analyst Ratings

$259.42
+0.68 (+0.26%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$256.95
$259.94
50-Day Range
$213.86
$262.19
52-Week Range
$212.40
$317.17
Volume
433,650 shs
Average Volume
844,987 shs
Market Capitalization
$24.05 billion
P/E Ratio
12.41
Dividend Yield
1.11%
Price Target
$299.75

Laboratory Co. of America Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$299.75
15.55% Upside
High Prediction$350.00
Average Prediction$299.75
Low Prediction$235.00
TypeCurrent
8/13/21 to 8/13/22
1 Month Ago
7/14/21 to 7/14/22
3 Months Ago
5/15/21 to 5/15/22
1 Year Ago
8/13/20 to 8/13/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
5 Buy rating(s)
6 Buy rating(s)
10 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$299.75$297.72$304.09$303.42
Predicted Upside15.55% Upside11.88% Upside12.81% Upside14.10% Upside
Get Laboratory Co. of America Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


LH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Laboratory Co. of America Stock vs. The Competition

TypeLaboratory Co. of AmericaMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.71
2.50
Consensus RatingModerate BuyBuyHold
Predicted Upside15.55% Upside724.28% Upside13.81% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
576
65.98%
Underperform Votes
297
34.02%
Avg. Outperform Votes
167
66.80%
Avg. Underperform Votes
83
33.20%
Avg. Outperform Votes
840
68.74%
Avg. Underperform Votes
382
31.26%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/9/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$308.00+20.42%
8/4/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$295.00 ➝ $297.00+17.25%
5/25/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$360.00 ➝ $300.00+20.99%
5/4/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$354.00 ➝ $323.00+31.67%
5/3/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$294.00 ➝ $265.00+9.05%
4/29/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$350.00 ➝ $320.00+32.97%
4/25/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$290.00 ➝ $235.00-12.48%
2/11/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$340.00 ➝ $350.00+24.03%
5/20/2021Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetAverage ➝ Buy$270.00 ➝ $295.00+10.47%
5/3/2021Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$300.00 ➝ $310.00+16.60%
2/12/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$261.00 ➝ $279.00+17.62%
1/8/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Steve Baxter
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
10/27/2020William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Larew
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
7/29/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Derik De Bruin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$220.00 ➝ $240.00+22.37%
7/29/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive ➝ Buy$220.00 ➝ $240.00+21.68%
5/5/2020UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$209.00 ➝ $218.00+35.19%
4/29/2020KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Sector Weight
4/23/2020Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$188.00 ➝ $195.00+26.52%
2/14/2020Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Newshel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$215.00+10.10%
2/13/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$177.00 ➝ $219.00+12.46%
(Data available from 8/13/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












LH Price Target - Frequently Asked Questions

What is Laboratory Co. of America's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Laboratory Co. of America stock is Moderate Buy based on the current 2 hold ratings and 4 buy ratings for LH. The average twelve-month price prediction for Laboratory Co. of America is $299.75 with a high price target of $350.00 and a low price target of $235.00. Learn more on LH's analyst rating history.

Do Wall Street analysts like Laboratory Co. of America more than its competitors?

Analysts like Laboratory Co. of America less than other Medical companies. The consensus rating for Laboratory Co. of America is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how LH compares to other companies.

Do MarketBeat users like Laboratory Co. of America more than its competitors?

MarketBeat users like Laboratory Co. of America less than other Medical companies. 65.98% of MarketBeat users gave Laboratory Co. of America an outperform vote while medical companies recieve an average of 66.80% outperform votes by MarketBeat users.

Does Laboratory Co. of America's stock price have much upside?

According to analysts, Laboratory Co. of America's stock has a predicted upside of 15.25% based on their 12-month price targets.

What analysts cover Laboratory Co. of America?

Laboratory Co. of America has been rated by Credit Suisse Group, Morgan Stanley, and Robert W. Baird in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:LH) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.